SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000318771-06-000005
Filing Date
2006-02-17
Accepted
2006-02-17 13:52:41
Documents
9
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 GENENTECH, INC. FORM 10-K FOR THE PERIOD ENDED 12/31/2005 form10-k.htm 10-K 2738675
2 BYLAWS dna-ex3_5.htm EX-3.5 90286
3 FIRST AMENDMENT TO TRANSITION AGREEMENT BETWEEN GENENTECH, INC. AND MYRTLE S. PO dna-ex10_23.htm EX-10.23 26265
4 FIRST AMENDMENT TO THE MANUFACTURING AND SUPPLY AGREEMENT BETWEEN GENENTECH, INC dna-ex10_28.htm EX-10.28 44660
5 FIRST AMENDMENT TO THE TOLL MANUFACTURING AGREEMENT BY AND BETWEEN WYETH, ACTING dna-ex10_30.htm EX-10.30 19315
6 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dna-ex23_1.htm EX-23.1 8747
7 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULES 13A-14(A) AND 15D-14( dna-ex31_1.htm EX-31.1 12241
8 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO RULES 13A-14(A) AND 15D-14( dna-ex31_2.htm EX-31.2 12569
9 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT T dna-ex32_1.htm EX-32.1 10953
  Complete submission text file 0000318771-06-000005.txt   2965106
Mailing Address 1 DNA WAY . SOUTH SAN FRANCISCO CA 94080
Business Address 1 DNA WAY SOUTH SAN FRANCISCO CA 94080 650-225-1000
GENENTECH INC (Filer) CIK: 0000318771 (see all company filings)

IRS No.: 942347624 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-09813 | Film No.: 06628382
SIC: 2834 Pharmaceutical Preparations